Therapeutic Advances in Cardiovascular Disease

@Sage_Publishing @SageJournals | CVD research 🫀🏥💊| Open access | IF: 3.3 & 5-year IF: 3.0 | Indexed in: MEDLINE, PMC, WoS, Scopus | Social Media: Amy Goundry

[Therapeutic Advances in Cardiovascular Disease @TACardio]

This review explores the growing role of coronary intravascular lithotripsy (IVL), from its mechanism of action and imaging guidance to evidence from the DISRUPT CAD trials and emerging applications in complex lesions.
https://t.co/4AltNb2dQK

[Sage Journals @SageJournals]

Sage’s How to Do Research and Get Published webinar series wins gold at 2026 EPIC Awards!

Find out more: https://t.co/jigbzreWob

[Therapeutic Advances in Cardiovascular Disease @TACardio]

Therapeutic Advances in Cardiovascular Disease
⭐New impact factor of 3.3 (5‑year impact factor: 3.0)
A platform for clinical, decision‑focused cardiovascular research, openly accessible to a global audience.
A huge thank you to our Editorial Board, authors, and reviewers!

[Therapeutic Advances in Cardiovascular Disease @TACardio]

Looking to share your research in a more accessible way? @TACardio welcomes PLS‑Ps, as well as video, podcast, & clinical image articles to help broaden reach and support engagement across wider audiences.
📩Considering these formats? Check requirements with the Managing Editor.

[Therapeutic Advances in Cardiovascular Disease @TACardio]

Writing up clinical research? Watch Sage's How to Do Research and Get Published webinar, "Mastering the Clinical Research Publication Journey: From Submitting to Publishing your Research", available on YouTube!
https://t.co/32Liy3Gm6V

[Therapeutic Advances in Cardiovascular Disease @TACardio]

Read this @TACardio review on sex-based differences across HF phenotypes and CV ageing mechanisms, summarising evidence on therapy response, and highlighting gaps due to under-representation in trials and under-treatment in practice.
https://t.co/dNWXcsBb1x

[Therapeutic Advances in Cardiovascular Disease @TACardio]

🎧 New podcast article (with transcript) in @TACardio!
https://t.co/2CqUD1d6jh

[Therapeutic Advances in Cardiovascular Disease @TACardio]

⏰Submit by 30 June to @TACardio Special Collections on:
🫀Optimising Outcomes in CV Surgery | 🩺Advancing Pediatric CV Care | 💊Targeting Inflammation & Immunity in CVD
https://t.co/7C9h9iNbF7

[Azmil Abdul-Rahim @AzmilAbdulRahim]

Check out our latest narrative review @TACardio: “Challenging anticoagulation decisions in #AFib.” 💊❤️🩺😷 @Dr_MGriffin @LiverpoolCCS @LivuniILCaMS @MWLNHSLib_STHK @LHCHFT [Click]
https://t.co/xzRMciRqrr

[Bo Xu MD, FACC, FASE @BoXuMD]

Relevance of cardiac imaging in the evolving landscape of infective endocarditis management
@TACardio @Star cardiology fellow Alice Haouzi MD @MdKhayata @CCFcards @CleClinicHVTI @ccf_echo_school #YesCCT

https://t.co/s4J72Fl1Jt

[Tuğba Kemaloğlu Öz, A/Prof @KemalogluOz]

Fresh off the press! Our review, “The pivotal role of echocardiography in structural heart interventions,” is now published in Therapeutic Advances in Cardiovascular Disease.
Thanks to all co-authors & special thanks to @ZainabDakhil2

https://t.co/zZXdwZTdqG
#echofirst #4Decho

[Therapeutic Advances in Cardiovascular Disease @TACardio]

"Optimizing Strategies, Care, and Outcomes in Cardiovascular Surgery" welcomes submissions of team‑based care pathways that clarify peri‑operative decisions, reduce complications, and enhance recovery.
🗓️ Collection open to submissions until June 30, 2026
https://t.co/XNNlcxWBw4.

[Sage Journals @SageJournals]

New to publishing or ready to level up your next paper?

From manuscript prep to peer review, open access, and promotion, Sage’s Information for Authors hub has you covered.

Publish smarter, with confidence: https://t.co/cazyxaPm5t

[Sage Journals @SageJournals]

Heart disease is a leading public health problem globally.

Explore the latest advances in cardiology with visual abstracts from @Innovationsjour and @HeartValveOrg on the Cardiology & Cardiovascular Medicine hub: https://t.co/sfaIlR51Xc

[Therapeutic Advances in Cardiovascular Disease @TACardio]

🌟Thank you to our Editorial Board and our global reviewer community! Your time, expertise, and thoughtful feedback power rigorous, clinically meaningful cardiovascular research in @TACardio.
https://t.co/XDrfWOUPqt

[Therapeutic Advances in Cardiovascular Disease @TACardio]

💬Meet the Editor sessions now available! An opportunity to speak with a @TACardio editor about how your research aligns with the journal, identify suitable Special Collections, and get guidance on submission requirements and peer review.
Book here: https://t.co/Q4Am2WJUqR

[Therapeutic Advances in Cardiovascular Disease @TACardio]

📢 Therapeutic Responses to Environmental Cardiovascular Risk
Part of a Special Collection series on Sustainable Development Goal 3: Good Health and Well-Being
🗓️ Submissions open until July 31, 2026
https://t.co/I8UrwL60eA

[Therapeutic Advances in Cardiovascular Disease @TACardio]

This Northern California pilot study explores how coordinated care and organisational structures relate to CABG outcomes, offering context that may be useful for refining surgical pathways and longer‑term management.
https://t.co/MOSi8CWlBx

[Therapeutic Advances in Cardiovascular Disease @TACardio]

Precision‑focused cardiovascular research helps relate patient characteristics, biomarkers, and risk profiles to clearer treatment pathways. @TACardio values evidence that strengthens personalised, data‑driven decisions and guides therapy selection.